title: Trial watch: hope renewed for strategy to raise HDL cholesterol.
mesh_terms: D000924:Anticholesteremic Agents / Q000494:pharmacology*; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D053480:Cholesterol Ester Transfer Proteins / Q000037:antagonists & inhibitors; D008076:Cholesterol, HDL / Q000097:blood / Q000187:drug effects*; D017322:Clinical Trials, Phase II as Topic; D050171:Dyslipidemias / Q000150:complications / Q000188:drug therapy; D006801:Humans; D023303:Oxazolidinones / Q000009:adverse effects / Q000494:pharmacology; D011804:Quinolines / Q000009:adverse effects / Q000494:pharmacology; D012307:Risk Factors
chemical_list: D000924:Anticholesteremic Agents; D053480:Cholesterol Ester Transfer Proteins; D008076:Cholesterol, HDL; D023303:Oxazolidinones; D011804:Quinolines; C483909:torcetrapib; C530884:anacetrapib